Systematic review and meta-analysis of humoral immunity proteins and mortality in sepsis.
Villa A., Dewar F., Pisciotta W., Rai A., Kerneis S., Batum G., McDonnell T., Scully M., McHugh TD., Hilpert K., Gilroy D., de Nooijer A., Netea MG., Hedetoft M., Bermejo-Martin JF., Akatsuka M., Heinz CC., Venet F., Monneret G., Meessen J., Cheng TH., Zhang M., Caironi P., Giamarellos-Bourboulis EJ., de la Torre Terrón MC., Ebelt H., Rademaker E., Bodelsson M., Tverring J., Mi Y., Knight JC., Lindsey ML., Langley RJ., Kingsmore SF., Brealey D., Singer M., Arulkumaran N.
PurposeHumoral immunity proteins-immunoglobulins, complement proteins, and antimicrobial peptides-have key antimicrobial and immunomodulatory functions in sepsis. We hypothesised that their circulating levels are lower in non-survivors, potentially resulting in impaired bacterial clearance and persistent or recurrent infections.MethodsWe performed a systematic review and meta-analysis evaluating differences in humoral immunity proteins between survivors and non-survivors in adult patients with sepsis. PubMed and Embase were searched without date restrictions. Random-effects meta-analyses were used to estimate pooled standardised mean differences (SMD) with 95% confidence intervals (CI). Sensitivity analyses included data from the MIMIC-IV ICU database, and further supplemented by three proteomic studies.ResultsThirty-six studies including 6,330 patients were analysed. Thirteen reported on immunoglobulins, 17 on complement proteins, and 7 on the antimicrobial peptide heparin-binding protein (HBP). Survivors had significantly higher levels of complement proteins C3 (SMD 0.53 [0.07-0.99]) and C4 (SMD 0.51 [0.09-0.94]) compared to non-survivors. Conversely, C4a (SMD - 1.17 [-1.77 to - 0.56]) and IgA (SMD - 0.21 [-0.39 to - 0.03]) were significantly lower in survivors. No differences were found for IgG (SMD 0.00 [-0.18 to 0.18]), IgM (SMD - 0.02 [-0.13 to 0.08]), C5, C5a, or HBP. Sensitivity analyses using MIMIC-IV (n = 2,452) and proteomic datasets supported these findings. Proteomic data revealed early depletion of classical complement components (C3, C4B) and regulatory proteins in non-survivors.ConclusionSepsis non-survivors exhibit lower C3 and C4 levels and higher C4a, consistent with complement activation and/or depletion. Complement proteins may serve as potential biomarkers and therapeutic targets in sepsis.